There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Prothena (PRTA – Research Report), Nurix Therapeutics (NRIX – Research Report) and Pacira Pharmaceuticals (PCRX – Research Report) with bullish sentiments.
Nurix Therapeutics (NRIX)
Needham analyst Gil Blum maintained a Buy rating on Nurix Therapeutics today and set a price target of $32.00. The company’s shares closed last Monday at $14.44.
According to TipRanks.com, Blum ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Nurix Therapeutics with a $35.67 average price target, representing a 146.3% upside. In a report issued on November 7, Robert W. Baird also maintained a Buy rating on the stock with a $31.00 price target.
Pacira Pharmaceuticals (PCRX)
Needham analyst Serge Belanger maintained a Buy rating on Pacira Pharmaceuticals today and set a price target of $74.00. The company’s shares closed last Monday at $50.50, close to its 52-week low of $47.40.
According to TipRanks.com, Belanger is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
Pacira Pharmaceuticals has an analyst consensus of Strong Buy, with a price target consensus of $73.71, a 38.8% upside from current levels. In a report issued on November 4, H.C. Wainwright also maintained a Buy rating on the stock with a $76.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PRTA:
- Here’s Why Analysts Love Alphabet Stock (NASDAQ: GOOGL)
- Barrington Remains a Buy on Lions Gate Entertainment Class A (LGF.A)
- Barrington Sticks to Their Hold Rating for fuboTV (FUBO)
- Consumers Energy, the Principal Subsidiary of CMS Energy, Declares Quarterly Dividend on Preferred Stock
- Lowell Farms Chairman of the Board George Allen to Speak at Cannavest West Conference in Las Vegas